[go: up one dir, main page]

TR199801797T2 - Bipolar disorder treatment. - Google Patents

Bipolar disorder treatment.

Info

Publication number
TR199801797T2
TR199801797T2 TR1998/01797T TR9801797T TR199801797T2 TR 199801797 T2 TR199801797 T2 TR 199801797T2 TR 1998/01797 T TR1998/01797 T TR 1998/01797T TR 9801797 T TR9801797 T TR 9801797T TR 199801797 T2 TR199801797 T2 TR 199801797T2
Authority
TR
Turkey
Prior art keywords
bipolar disorder
disorder treatment
treatment
zapin
seizure
Prior art date
Application number
TR1998/01797T
Other languages
Turkish (tr)
Inventor
Merritt Beasley Charles
Dennis Tollefson Gary
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of TR199801797T2 publication Critical patent/TR199801797T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)

Abstract

Bulus olan zapinin etkili bir miktarinin memelilerde Iki Kutuplu Bozukluk, Majör Depresyon Nöbetinin yani sira iki kutuplu bozukluk tedavisine yönelik bir ilacin imalatinda kullanimina iliskindir.It relates to the use of an effective amount of invented zapin in the manufacture of a drug for the treatment of bipolar disorder, as well as the Major Depression Seizure in mammals.

TR1998/01797T 1996-03-11 1996-12-04 Bipolar disorder treatment. TR199801797T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1315996P 1996-03-11 1996-03-11

Publications (1)

Publication Number Publication Date
TR199801797T2 true TR199801797T2 (en) 1998-12-21

Family

ID=21758606

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/01797T TR199801797T2 (en) 1996-03-11 1996-12-04 Bipolar disorder treatment.

Country Status (15)

Country Link
EP (1) EP0889725A4 (en)
JP (1) JP2000506859A (en)
KR (1) KR19990087713A (en)
CN (1) CN1213966A (en)
AU (1) AU734011B2 (en)
BR (1) BR9612548A (en)
CZ (1) CZ290298A3 (en)
EA (1) EA000758B1 (en)
HU (1) HUP9903679A3 (en)
IL (1) IL126162A0 (en)
NO (1) NO984189D0 (en)
NZ (1) NZ326031A (en)
PL (1) PL328925A1 (en)
TR (1) TR199801797T2 (en)
WO (1) WO1997033577A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960577B2 (en) 1998-05-22 2005-11-01 Eli Lilly And Company Combination therapy for treatment of refractory depression
AU761510B2 (en) * 1998-05-22 2003-06-05 Eli Lilly And Company Combination therapy for treatment of refractory depression
WO1999062522A1 (en) * 1998-05-29 1999-12-09 Eli Lilly And Company Combination therapy for treatment of bipolar disorders
PT1133300E (en) 1998-11-23 2005-04-29 Sepracor Inc DESMETILOLANZAPINE COMPOSITIONS AND METHODS
AU757874B2 (en) 1998-11-23 2003-03-06 Sepracor, Inc. 2-hydroxymethylolanzapine compositions and methods
ES2211205T3 (en) * 1998-11-23 2004-07-01 Sepracor Inc. PHARMACEUTICAL COMPOSITIONS CONTAINING OLANZAPINE-N-OXIDE.
JP6440625B2 (en) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー Methods and compositions for treating schizophrenia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use

Also Published As

Publication number Publication date
HUP9903679A2 (en) 2000-04-28
CZ290298A3 (en) 1999-10-13
NO984189L (en) 1998-09-11
IL126162A0 (en) 1999-05-09
CN1213966A (en) 1999-04-14
NO984189D0 (en) 1998-09-11
AU1330797A (en) 1997-10-01
EA199800819A1 (en) 1999-02-25
EP0889725A4 (en) 2000-01-19
EP0889725A1 (en) 1999-01-13
JP2000506859A (en) 2000-06-06
EA000758B1 (en) 2000-04-24
HUP9903679A3 (en) 2001-10-29
WO1997033577A1 (en) 1997-09-18
KR19990087713A (en) 1999-12-27
NZ326031A (en) 2001-05-25
PL328925A1 (en) 1999-03-01
AU734011B2 (en) 2001-05-31
BR9612548A (en) 1999-07-20

Similar Documents

Publication Publication Date Title
TR200102800T2 (en) New compounds.
NO963239D0 (en) Chloropyrimid intermediates
TR200000782T2 (en) Resorcinol derivatives.
ES2186874T3 (en) ANALOGS OF M-AMIDINOPHENYL AS INHIBITORS OF FACTOR XA.
TR200200972T2 (en) Substituted 2-phenylbenzimidazoles, their production and uses
BR0007527A (en) Phenylphenanthridines with IV-dependent inhibitory activity
ES2184077T3 (en) NEW FENANTRIDINS REPLACED IN POSITION 6.
PT966447E (en) SMALL UTILIZATION MOLECULES IN THE TREATMENT OF INFLAMMATORY DISEASES
TR200200205T2 (en) Treating chronic pain using MEK inhibitors
EA200100315A1 (en) SIMPLE TETRAHYDROPYRIDE ETHERS
TR200102338T2 (en) Cyclic substituted linked pyrolocarbazoles and isoindolones.
BR9713338A (en) Benzonaphyridines as bronchial therapeutics.
DK0973544T3 (en) Immune tolerant prothrombin complex preparation
DE50111331D1 (en) NEW USE OF PROTEIN HYDROLYSATES
DE60033918D1 (en) POLYSUBSTITUTED 6-PHENYLPHENANTHRIDINES WITH PDE-IV HEMMENDER EFFECT
TR199801797T2 (en) Bipolar disorder treatment.
DE60025327D1 (en) 6-ARYLPHENANTHRIDINE WITH PDE-IV HEMMENDER EFFECT
ATE59781T1 (en) POTENTIATION OF PRAZOSIN.
ES2020953B3 (en) TETRAHYDRO-3,4-FURANODIAMINE-N-N'PLATINO COMPLEXES.
DK1143917T3 (en) Anti-convulsive derivatives suitable for the treatment of post-traumatic stress disorder
TR200003203T2 (en) Purification of carboxaldehyde
PT1244614E (en) TRIPTASE INHIBITORS
EA200001097A1 (en) STABLE COMPOSITIONS CONTAINING LEEVOSIMENDAN AND ALGINIC ACID
ATE213236T1 (en) SUBSTITUTED BENZYLOXYIMINO COMPOUNDS
ATE40116T1 (en) 1-ACYL-3-PYRIDYLMETHYLGUANIDINE AND THEIR USE AS ANTIHYPERTENSIVES.